Anthropometric and laboratory characteristics of women with sarcopenia
| Sarcopenia | P values | ||
| Yes | No | ||
| n=45 | n=131 | ||
| Age (years) | 80.1±5.2 | 75.6±8.7 | <0.01 |
| Height (cm) | 145.5±5.2 | 149.9±5.9 | <0.01 |
| Weight (kg) | 43.7±6.3 | 51.8±7.0 | <0.01 |
| BMI (kg/m2) | 20.7±2.9 | 23.0±2.8 | <0.01 |
| FMI (kg/m2) | 6.4±2.4 | 7.7±2.3 | 0.002 |
| SMI (kg/m2) | 5.1±0.4 | 6.0±0.6 | <0.01 |
| Waist circumference (cm) | 83.2±9.5 | 87.5±8.9 | 0.007 |
| Fat mass (kg) | 13.5±5.2 | 17.2±5.2 | <0.001 |
| Skeletal muscle mass (kg) | 10.8±1.1 | 13.4±1.9 | <0.001 |
| Grip strength (kg) | 14.9±2.6 | 21.6±4.5 | <0.001 |
| PB glucose (mg/dL) | 99±43 | 100±23 | 0.828 |
| PB insulin (μU/mL) | 7.0±6.1 | 8.5±7.4 | 0.327 |
| PB triglycerides (mg/dL) | 128±66 | 142±81 | 0.254 |
| Cholesterol (mg/dL) | 208±26 | 222±33 | 0.005 |
| HDL cholesterol (mg/dL) | 64±13 | 63±15 | 0.664 |
| Leptin (ng/mL) | 6.6±4.4 | 8.1±4.7 | 0.059 |
| Adiponectin (mg/L) | 16.6±7.9 | 13.2±7.8 | 0.010 |
| Leucocytes (109/L) | 6.2±1.6 | 6.1±1.6 | 0.796 |
| PAI-1 (ng/mL) | 23±11 | 25±12 | 0.368 |
| hsCRP (μg/dL) | 74±84 | 90±119 | 0.407 |
| TNF-α (pg/mL) | 1.7±0.8 | 1.7±1.1 | 0.764 |
| Red blood cells (1012/L) | 417±39 | 424±34 | 0.205 |
| Hemoglobin (g/l) | 126±10 | 129±11 | 0.113 |
| Hematocrit (%) | 40.4±3.0 | 40.9±3.4 | 0.411 |
| Albumin (g/dL) | 4.30±0.27 | 4.41±0.25 | 0.009 |
| Iron (μg/dL) | 93±28 | 94±27 | 0.815 |
| Copper (μg/dL) | 111±18 | 109±14 | 0.393 |
| Zinc (μg/dL) | 74±10 | 78±11 | 0.057 |
| Transthyretin (mg/dL) | 26±5 | 28±5 | 0.049 |
| Creatinine (mg/dL) | 0.66±0.13 | 0.70±0.16 | 0.141 |
| eGFR (mL/min/1.73 m2) | 66±13 | 64±13 | 0.366 |
| Anemia (n, %) | 12, 27.3 | 24, 18.3 | 0.146 |
| CKD3b (n, %) | 4, 8.9 | 8, 6.1 | 0.506 |
| Hyperadiponectinemia (n, %) | 15, 33.3 | 19, 14.5 | 0.007 |
Mean±SD or n, %.
BMI, body mass index; CKD, chronic kidney disease; FMI, fat mass index; HDL, high-density lipoprotein; PAI-1, plasminogen activator-inhibitor-1; PB, post-breakfast; RBC, red blood cells; SMI, skeletal muscle mass index; TNF-α, tumor necrosis factor-alpha; eGFR, estimated glomerular filtration rate; hsCRP, high-sensitivity C-reactive protein.